HistoSonics Overview
- Year Founded
-
2009

- Status
-
Private
- Employees
-
182

- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$102M
- Investors
-
24
HistoSonics General Information
Description
Developer of a novel, non-invasive sonic beam therapy platform designed to liquefy and destroy targeted tissues at a sub-cellular level. The company's platform delivers personalized, tissue-specific treatments with unparalleled precision and control and without the undesirable side effects of many of today's interventional and surgical modalities, enabling physicians to monitor the treatment and its effect in real time continuously.
Contact Information
Website
www.histosonics.comCorporate Office
- 16305 36th Avenue North
- Suite 300
- Plymouth, MN 55446
- United States
Corporate Office
- 16305 36th Avenue North
- Suite 300
- Plymouth, MN 55446
- United States
HistoSonics Timeline
HistoSonics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Later Stage VC (Series D) | 15-Aug-2024 | $102M | Completed | Generating Revenue | ||
7. Later Stage VC (Series D) | 13-Dec-2022 | Completed | Generating Revenue | |||
6. Later Stage VC (Series C1) | 15-Apr-2020 | Completed | Generating Revenue | |||
5. Later Stage VC (Series C) | 05-Apr-2019 | Completed | Generating Revenue | |||
4. Later Stage VC (Series B) | 08-Feb-2017 | Completed | Generating Revenue | |||
3. Debt - General | 01-Dec-2015 | Completed | Generating Revenue | |||
2. Later Stage VC (Series A) | 16-May-2014 | $14.2M | $14.2M | Completed | Generating Revenue | |
1. Accelerator/Incubator | 01-Jan-2010 | Completed | Startup |
HistoSonics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series D-1 | ||||||||
Series D-2 | ||||||||
Series C1 | ||||||||
Series C | ||||||||
Series B | 25,110,459 | $0.001000 | $0.04 | $0.55 | $0.55 | 1x | $0.55 | 6.57% |
Series A | 16,262,314 | $0.001000 | $0.06 | $1 | $1 | 1x | $1 | 4.25% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
HistoSonics Comparisons
Industry
Financing
Details
HistoSonics Competitors (7)
One of HistoSonics’s 7 competitors is Profound Medical, a Formerly VC-backed company based in Mississauga, Canada.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Profound Medical | Formerly VC-backed | Mississauga, Canada | ||||
RefleXion (Biotechnology) | Venture Capital-Backed | Hayward, CA | ||||
Insightec | Venture Capital-Backed | Tirat Carmel, Israel | ||||
ViewRay | Formerly VC-backed | Bedford, OH | ||||
Boston Scientific | Corporation | Marlborough, MA |
HistoSonics Patents
HistoSonics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20250090130-A1 | Co-registration techniques between computed tomography imaging systems and histotripsy robotic systems | Pending | 19-Sep-2023 | ||
US-20250090871-A1 | Simulation software and tools for evaluating histotripsy therapy for a given pose and position of a therapy array | Pending | 15-Sep-2023 | ||
US-20240350153-A1 | Histotripsy systems and associated methods including user interfaces and workflows for treatment planning and therapy | Pending | 20-Apr-2023 | ||
US-D1065226-S1 | Display screen or portion thereof with an animated graphical user interface | Active | 20-Apr-2023 | ||
US-D1065246-S1 | Display screen or portion thereof with an animated graphical user interface | Active | 20-Apr-2023 |
HistoSonics Signals
HistoSonics Investors (24)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Amzak Health | Venture Capital | Minority | ||
HealthQuest Capital | Growth/Expansion | Minority | ||
Alpha Wave Global | Growth/Expansion | Minority | ||
Gary Comer | PE/Buyout | Minority | ||
Trout Creek Ventures | Venture Capital | Minority |
HistoSonics FAQs
-
When was HistoSonics founded?
HistoSonics was founded in 2009.
-
Where is HistoSonics headquartered?
HistoSonics is headquartered in Plymouth, MN.
-
What is the size of HistoSonics?
HistoSonics has 182 total employees.
-
What industry is HistoSonics in?
HistoSonics’s primary industry is Surgical Devices.
-
Is HistoSonics a private or public company?
HistoSonics is a Private company.
-
What is the current valuation of HistoSonics?
The current valuation of HistoSonics is
. -
What is HistoSonics’s current revenue?
The current revenue for HistoSonics is
. -
How much funding has HistoSonics raised over time?
HistoSonics has raised $329M.
-
Who are HistoSonics’s investors?
Amzak Health, HealthQuest Capital, Alpha Wave Global, Gary Comer, and Trout Creek Ventures are 5 of 24 investors who have invested in HistoSonics.
-
Who are HistoSonics’s competitors?
Profound Medical, RefleXion (Biotechnology), Insightec, ViewRay, and Boston Scientific are some of the 7 competitors of HistoSonics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »